News and Trends 5 Oct 2022
CanSinoBIO to present latest data on inhaled COVID vaccine
CanSino Biologics Inc. will be presenting clinical trial data for the recombinant COVID-19 vaccine (adenovirus type 5 vector) for inhalation (with the trade name Convidecia Air) at World Vaccine Congress…